The score is driven down primarily by severe financial stress (deep losses, negative gross profit in 2025, persistent cash burn, and a pressured balance sheet). Technicals add further risk given a clear downtrend despite oversold readings. Valuation provides limited support because negative earnings make P/E uninformative and no dividend yield is available.
Positive Factors
Infection-prevention product focus
A clear, specialized focus on hygiene and infection-prevention targets durable end markets (healthcare, public facilities, professional cleaning). Structural demand for infection control supports recurring product and service needs, aiding long-term revenue stability if execution matches market requirements.
Reported reduction in total debt (2025)
Lower reported debt in 2025 versus prior years modestly reduces immediate solvency pressure and lengthens runway versus earlier peaks. This improvement, if sustained, increases financial flexibility to execute restructuring or commercial recovery without immediate refinancing urgency.
Improvement in EBITDA losses versus 2024
An improvement in EBITDA losses indicates operational leverage or cost control progress, which is a durable sign management can stabilize operations. If maintained, this can form the foundation for margin recovery and reduce future cash burn requirements over the coming quarters.
Negative Factors
Persistent negative operating and free cash flow
Consistent negative operating and free cash flow signals the business is burning cash rather than self-funding. Over a multi-quarter horizon this necessitates external financing or asset sales, which can dilute shareholders, increase leverage, or force cutbacks that impede growth and execution.
Negative gross profit in 2025
A negative gross profit means core product economics were unfavorable in 2025; costs exceeded revenue before overhead. This is a structural red flag: without pricing, mix, or cost-of-goods improvements the business model is not sustainable and margin recovery is required to avoid ongoing losses.
High leverage and thin/unstable equity
High leverage and thin or negative equity raise solvency and refinancing risk, limiting the company's ability to absorb shocks or fund growth. Over the medium term this constrains strategic options and increases probability of distress-driven outcomes absent sustained profitability or fresh capital.
LifeClean International AB (LCLEAN) vs. iShares MSCI Sweden ETF (EWD)
Market Cap
kr14.03M
Dividend YieldN/A
Average Volume (3M)474.43K
Price to Earnings (P/E)―
Beta (1Y)-0.12
Revenue Growth-15.74%
EPS Growth44.98%
CountrySE
Employees31
SectorConsumer Defensive
Sector Strength42
IndustryHousehold & Personal Products
Share Statistics
EPS (TTM)-0.03
Shares Outstanding274,110,400
10 Day Avg. Volume395,019
30 Day Avg. Volume474,432
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)7.74
Price to Sales (P/S)0.48
P/FCF Ratio-0.92
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.06
Revenue Forecast (FY)kr135.00M
LifeClean International AB Business Overview & Revenue Model
Company DescriptionLifeClean International AB (publ) researches, produces, markets, and sells disinfection products in Sweden. It has developed a patented spore, fungal, biofilm, bacterial, and virus-killing surface disinfection for equipment and surfaces, such as floors, walls, furniture, and general roof surfaces. The company was founded in 2012 and is based in Uddevalla, Sweden.
How the Company Makes MoneyLCLEAN generates revenue through several key streams, primarily from the direct sales of its eco-friendly cleaning products to retail and wholesale distributors. The company also engages in business-to-business (B2B) partnerships, supplying products to commercial cleaning services, hotels, and healthcare facilities, which account for a significant portion of its sales. Additionally, LCLEAN has established strategic partnerships with environmental organizations to enhance brand visibility and credibility, further driving sales through co-marketing efforts. The company's online sales platform also contributes to its revenue, allowing direct access to consumers and expanding its market reach. Overall, LCLEAN's revenue model is centered on product sales, strategic partnerships, and a growing e-commerce presence.
LifeClean International AB Financial Statement Overview
Summary
Very weak fundamentals: revenue fell sharply in 2025 (~44% YoY), losses are persistent with extremely negative margins (including negative gross profit in 2025), operating/free cash flow are negative every year (worsening cash burn in 2023–2025), and the balance sheet shows high leverage with a thin/unstable equity cushion (including negative equity in 2024).
Income Statement
18
Very Negative
Revenue has been volatile and recently declined (2025 revenue down ~44% year over year), following modest growth in 2023–2024. Profitability is very weak: net losses persist every year shown, with extremely negative net margins (roughly -65% in 2025 and near -88% in 2024). A key concern is gross profitability deterioration—2025 shows a negative gross profit (and negative gross margin), indicating the core product economics were unfavorable in the latest year despite some improvement in EBITDA losses versus 2024.
Balance Sheet
22
Negative
Leverage is high and balance-sheet strength has deteriorated versus earlier years. Debt is substantial relative to equity, and equity has been thin/unstable (including negative equity in 2024), which raises financing and solvency risk. While total debt came down from 2023–2024 levels into 2025, the company is still operating with very limited equity cushion and deeply negative returns for shareholders in most years shown.
Cash Flow
14
Very Negative
Cash generation is a major weakness: operating cash flow is negative in every year shown, and free cash flow is also consistently negative, worsening sharply in recent years (large outflows in 2023–2025). While free cash flow broadly tracks the net loss (losses converting into cash burn rather than being accounting-only), the continued cash drain implies ongoing reliance on external funding or balance-sheet flexibility to sustain operations.
Breakdown
Dec 2025
Dec 2024
Dec 2023
Dec 2022
Dec 2021
Income Statement
Total Revenue
54.63M
61.15M
52.50M
47.18M
53.36M
Gross Profit
-35.33M
26.82M
22.77M
19.52M
-30.81M
EBITDA
-26.03M
-40.87M
-32.39M
-27.79M
-26.05M
Net Income
-35.66M
-53.72M
-44.24M
-36.09M
-32.75M
Balance Sheet
Total Assets
48.10M
61.80M
68.61M
76.37M
82.59M
Cash, Cash Equivalents and Short-Term Investments
6.88M
10.57M
8.29M
11.61M
8.85M
Total Debt
27.36M
44.90M
47.84M
32.38M
18.54M
Total Liabilities
44.73M
65.43M
67.29M
62.56M
32.70M
Stockholders Equity
3.36M
-3.63M
1.31M
13.81M
49.89M
Cash Flow
Free Cash Flow
-28.28M
-42.66M
-39.99M
-20.07M
-23.01M
Operating Cash Flow
-28.23M
-40.83M
-35.46M
-16.96M
-21.79M
Investing Cash Flow
45.00K
-1.85M
-4.54M
-3.13M
-36.51M
Financing Cash Flow
24.50M
44.96M
36.67M
22.84M
24.68M
LifeClean International AB Technical Analysis
Technical Analysis Sentiment
Negative
Last Price0.09
Price Trends
50DMA
0.07
Negative
100DMA
0.10
Negative
200DMA
0.14
Negative
Market Momentum
MACD
>-0.01
Negative
RSI
39.64
Neutral
STOCH
43.86
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:LCLEAN, the sentiment is Negative. The current price of 0.09 is above the 20-day moving average (MA) of 0.05, above the 50-day MA of 0.07, and below the 200-day MA of 0.14, indicating a bearish trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 39.64 is Neutral, neither overbought nor oversold. The STOCH value of 43.86 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SE:LCLEAN.
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 10, 2026